You searched for T cells - Page 22 of 41

paris ermium therapeutics autoimmune disease

Startup Scout 18 Oct 2019

This Biotech Fights Autoimmune Disease with Rare Immune Cells

…trials in three years. What we think: There is a strong need for autoimmune disease drugs that are able to restrain autoimmune cells while leaving the rest of the immune…

October 18, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 1 Sep 2022

New discovery could lead to drug development for brain cancer

…astrocytes are essential to tumor progression and survival. Therefore, we investigated the underlying mechanisms: How do astrocytes transform from cells that support normal brain activity into cells that support malignant…

September 1, 2022 - 6 minutesmins - By Jim Cornall

cancer cell therapy immunotherapy achilles therapeutics

News and Trends 3 Sep 2019

UK Biotech’s Personalized Immunotherapy gets €110M Series B Boost

…lymphocytes from patients’ tumor samples. The company cultures the T cells and clones the ones that target neoantigens — proteins that are on the surface of the patients’ cancer cells….

September 3, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 29 Feb 2016

It’s Rare Disease Day 2016: Here are 7 Indications which Biotech is Fighting

…to be working on them. This is not a comprehensive list (for sure), but just an example of some of the range of disease types and potential therapeutics out there….

February 29, 2016 - 6 minutesmins - By Dani Bancroft

News and Trends 24 Nov 2022

AI works on artificial DNA for future drug development

…The researchers have developed their method in the yeast Saccharomyces cerevisiae, whose cells resemble mammalian cells. The next step is to use human cells. The researchers hope their progress will…

November 24, 2022 - 4 minutesmins - By Jim Cornall

In Depth 28 May 2025

Myasthenia gravis treatments: what’s on the horizon?

…Cartesian Therapeutics’ Descartes-08 is an autologous mRNA CAR-T cell therapy, meaning that it uses a patient’s own T cells that have been modified with mRNA to help them better target…

May 28, 2025 - 10 minutesmins - By Roohi Mariam Peter

Cleara Biotech closes $2.5M round for senescence treatment

News and Trends 28 Sep 2022

Cleara Biotech closes $2.5M seed financing round to progress senescence treatment

Cleara Biotech has closed a $2.5 million seed financing round that it will use for progress its compounds toward clinical development. The company that develops therapies for treating different pathologies…

September 28, 2022 - 4 minutesmins - By Liza Laws

News and Trends 31 Jan 2023

BiVictriX announces positive data from leukemia study

…and provide further evidence that our first-in-class platform offers the potential to deliver the next generation of highly selective, anti-cancer therapies. Generating data that demonstrates BVX001 was well-tolerated in this…

January 31, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 1 Nov 2022

Human Immunology Biosciences launches with $120M

…and therapeutic engineering. This discovery toolkit leverages emerging insights from research and development efforts to profile the immune phenotypes that drive IMDs. The toolkit will allow HI-Bio to rapidly advance…

November 1, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 2 Apr 2025

Top biotech deals of March 2025

…in an all-cash transaction, according to a press release. The two have cooperated together over the years to develop and commercialize Abecma, a CAR-T cell therapy for multiple myeloma, which…

April 2, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 12 Jan 2016

Cellectis has Discovered an ‘On-Switch’ to Make CAR-T Safer and Better Controlled

…in how the CAR-T cells are deployed, taken up and act on cancerous cells. Simply put, there’s a lot of fine-tweaking and R&D to be done before CAR-T can truly…

January 12, 2016 - 3 minutesmins - By Dani Bancroft

Best in Biotech 7 Nov 2024

Cystic fibrosis: Five biotechs breathing life into the therapeutic space

…dry powder. The nebulized version of the drug is what is being evaluated to treat cystic fibrosis. The drug works by blocking the sodium channel (ENaC) in the cells that…

November 7, 2024 - 8 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: T cells

This Biotech Fights Autoimmune Disease with Rare Immune Cells

New discovery could lead to drug development for brain cancer

UK Biotech’s Personalized Immunotherapy gets €110M Series B Boost

It’s Rare Disease Day 2016: Here are 7 Indications which Biotech is Fighting

AI works on artificial DNA for future drug development

Myasthenia gravis treatments: what’s on the horizon?

Cleara Biotech closes $2.5M seed financing round to progress senescence treatment

BiVictriX announces positive data from leukemia study

Human Immunology Biosciences launches with $120M

Top biotech deals of March 2025

Cellectis has Discovered an ‘On-Switch’ to Make CAR-T Safer and Better Controlled

Cystic fibrosis: Five biotechs breathing life into the therapeutic space

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!